Novo Nordisk affirms 25% weight-loss expectation for experimental drug CagriSema
Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...
Novo Nordisk aware of reports 10 people taking compounded weight-loss drug copies died
Novo Nordisk said on Wednesday it was aware of reports of 10 deaths and 100 hospitalisations of people who had taken compounded copies of its weight-loss and diabetes drugs. U.S. regulations allow ...
Woman's World on MSN6 小时
Can Ozempic Relieve Knee Pain? New Study Offers Insight
Osteoarthritis of the knee is a common and often painful condition affecting millions worldwide, especially older adults. As ...
malaymail6 小时
Novo Nordisk says its experimental drug CagriSema has similar side effects to Wegovy
LONDON, Nov 7 — Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar ...
Yen on MSN19 小时
Obesity drug maker Novo Nordisk posts strong profit
Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted ...
nation13 小时
Risper Faith: No, I won't stop doing cosmetic surgeries
While Risper believes body enhancements can make companies choose one influencer over another, she emphasises that it is a ...
Youthful Hands and Skin Tightening: A Plastic Surgeon Predicts 2025 Trends
Another trend Srinivasa expects to see in 2025 is more skin-tightening procedures, following the growing popularity of weight loss drugs such as Wegovy.